Neoadjuvant Anti-PD-1 Strategy Prevails Over Adjuvant in Resectable Melanoma
Large increase in event-free survival with neoadjuvant plus adjuvant versus only adjuvant therapy
Stay updated with breaking news from James Larkin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Large increase in event-free survival with neoadjuvant plus adjuvant versus only adjuvant therapy
New trial results show that pembrolizumab given both before and after surgery for stage 2B-3 melanoma improved event-free survival compared with adjuvant therapy alone.
Poachers have been decimating the rhino population for years but a professor from Wits University believes radioactive technology could help.
Preoperative immunotherapy combo in dMMR disease yields major pathologic response in 95%
An 'innovative' study of short-course nivolumab plus ipilimumab prior to resection of MMR-deficient colon cancer has achieved 'unprecedented' pathologic responses, with no recurrences.